To assess the importance of the sympathetic nervous system in regulating body weight during prolonged leptin infusion, we evaluated food intake, body weight and physical activity in conscious, unrestrained rats. Initial studies illustrated that prolonged intracerebroventricular (ICV) infusion of leptin enhanced substrate oxidation so that adipose tissue lipid stores were completely ablated and muscle triglyceride and liver glycogen stores were depleted. Following neonatal chemical sympathectomy, changes in weight and food intake were compared for groups of sympathectomized (SYM) and control (CON) adult animals during ICV infusion of leptin.
INTRODUCTION
Administration of leptin in normal rodents activates the ventromedial hypothalamus, resulting in both anorexia and increased sympathetic stimulation of peripheral tissues (7, 19, 42) .
Seminal studies indicate that leptin infusion enhances daily energy expenditure in food restricted animals by preventing circadian decreases in resting energy expenditure that are normally observed during the first few hours of the light cycle (22, 39 14, 51, 52) . It is postulated that this effect is mediated via disinhibition of sympathetically-mediated thermogenesis (14) . On the other hand, fatty (fa/fa) rats with a mutation in the gene encoding the long form of the leptin receptor that disrupts intracellular signaling events (11, 24, 25, 44, 55, 56) develop profound obesity that is linked to impaired sympathetic regulation of peripheral metabolism (33, 34, 37) .
Despite the straightforward results obtained in the aforementioned animal models, questions remain regarding the role sympathetic activation plays in regulating body weight. Decreased sympathetic activity is associated with weight gain in rodent models of obesity but muscle sympathetic nerve activity (MSNA) measured by direct recordings obtained from the peroneal nerve is increased in obese human subjects (49, 50) . Furthermore, peripheral sympathetic nerve terminals have been destroyed in rats by triggering an immune-mediated response with repeated injections of guanethidine or 6-hydroxy-dopamine (27) (28) (29) . Surprisingly, chemically sympathectomized rats do not gain more weight than untreated littermates, even when challenged with a high fat diet (27, 29, 35, 45) . Given the complex nature of the multiple processes controlling energy balance, it is likely that additional mechanisms are triggered that compensate for the loss of peripheral sympathetic nerves. If a second factor is introduced, such as anorexia induced by leptin, the metabolic consequences of chemical sympathectomy may be unmasked. The following experiments test the hypothesis that chemical sympathectomy blunts E-00128.2002.R2 4 metabolic responses and limits weight loss during prolonged intracerebroventricular (ICV) leptin infusion.
ICV infusion of leptin places the hormone directly in the central nervous system (CNS) where it can stimulate the ventromedial hypothalamus without achieving circulating concentrations that could directly affect peripheral target tissues. While ICV infusion is an important technique for distinguishing CNS effects mediated through autonomic signals from peripheral actions of leptin, it is important to carefully characterize the response to this relatively nonphysiological mode of hormone administration for comparison to other models of hyperleptinemia. Therefore, a separate important goal of these studies is to measure the time course for metabolic and hormonal changes during prolonged ICV leptin infusion in normal rats.
METHODS AND MATERIALS
Animals Care. Male Sprague Dawley rats weighing 250-300 g were obtained from Harlan Sprague Dawley Co., Indianapolis, IN. They were housed in approved animal facilities at a temperature of 22°C and maintained on a 12 h light-dark cycle (lights on from 10 AM to 10 PM) with ad libitum access to water and powdered standard 4% fat rat chow prepared by Harlan Teklad, Madison, WI. Studies were performed after the rats had been acclimated to the new facilities for at least 3 days and all protocols were approved by the UT-Southwestern Medical Lakes, FL). The dorsal third ventricle was cannulated at stereotaxic coordinates CV = bregma -2.2 mm and AP = bregma -4.5 mm using a 28-gauge, 6 mm long osmotic pump connector cannula (Plastics One Inc., Wallingford, CT). The apparatus was cemented into place with dental cement and the intracerebroventricular (ICV) cannula was connected to an osmotic minipump (model 2002, Durect Corp., Cupertino, CA) using a PE-60 catheter. The pump was placed in a subcutaneous pouch made in the interscapular region and the incision was closed.
Surgery was performed using aseptic technique and the overall success rate of the procedure was 85-90%. In initial investigations, correct placement of the catheter was confirmed by autopsy to determine the ventricular distribution of methylene blue dye injected via the infusion catheter.
An arterial catheter was required to measure plasma parameters in selected protocols.
While the rats were still anesthetized immediately following insertion of the ICV catheter, a sampling catheter was placed into the right common carotid artery using a previously established protocol (12, 54) .
ICV Leptin Administration and Fat-Free Mass. We obtained highly purified recombinant leptin from Novo Nordisk Pharmaceutical prepared as previously described (57 while the other half were pair fed to the leptin group (PF). Body weight, food intake, water ingestion and urinary nitrogen excretion were monitored daily. Food spillage was accounted for by weighing any food that fell through the floor of the cage into the collecting apparatus. On days 3, 6 and 10, the animals were transported to the NMR facility and briefly anesthetized with methoxyflurane. 1 H spectra of the entire animal were collected with a 4.7T OMEGA system using established pulse sequences (13, 17, 23, 40, 53) and the resulting water and fat resonances were quantified after line-fitting with NUTS software (ACORNNMR, Fremont, CA). Fat mass and fat-free mass were computed from the ratio of fat and water signal areas and known ratios of proton densities of fatty acid chains and water assuming that water comprises 72% of fat-free mass (48) . Fat-free mass = body mass ÷ (1 + fat:water ratio x 0.72) and fat mass = body massfat-free mass. The NMR technique was validated by previous investigators, the correlation coefficient between total body lipid and water content measured by HMRS and classical carcass analysis being 0.97 (40) . or the dilution vehicle. To limit confounding effects of stress from additional procedures, we monitored only food intake and body weight for 10 days in 4 initial groups of rats: control + vehicle (n=7), control + leptin (n=12), sympathectomy + vehicle (n=7) and sympathectomy + leptin (n=11). A fifth group, control + leptin + pair-fed (n=8), was added to account for differences in food intake between the two leptin-treated groups.
ICV
Physical activity during leptin administration was evaluated using the Opto-Varimex-3
Auto-Track System from Columbus Instruments, Columbus, OH that has been previously described (16) . Briefly, separate animals (n=5-6 per group) were placed into individual cages at 5 PM on the fourth postoperative day with free access to food and water and experiments were initiated at 10 PM when the lights turned off. Data was collected and analyzed to assess total active time and total distance traveled during the first 8 hours of the dark cycle.
Analytical Procedures and Materials. Plasma glucose concentrations were measured by the glucose oxidase method on a Beckman Glucose Analyzer II machine purchased from Beckman Industries, Inc., Fullerton. CA. Plasma FFA concentrations were determined by a colorimetric assay incorporating fatty acyl-CoA synthetase, acyl-CoA oxidase, and a peroxidase-linked reagent (Boehringer Mannheim Corp, Indianapolis, IN). Plasma TG concentrations were measured using a baseline-correction for glycerol (Sigma Diagnostics, St. Louis, MO). Urinary nitrogen content was calculated as the sum of urine ammonia, uric acid and creatinine content measured using kits obtained from Sigma Diagnostics. Insulin and leptin levels in plasma were determined by radioimmunoassays using kits specific for rat insulin and leptin purchased from 
RESULTS

Time Course of Leptin's Effect in Dissipating Adipose
Tissue. The initial objective of these investigations was to closely characterize the time course for the metabolic actions of ICV leptin in normal rats maintained in metabolic cages. Figure 1 illustrates the changes in food intake, body mass and percent body fat that were observed as leptin-treated, vehicle and pair-fed rats were followed for ten days. Treatment with leptin inhibited food intake but the anorexic effect waned from days 6 to 10 compared to the response noted earlier in the course of treatment. The control rats receiving the dilution vehicle had a stable body weight compared with a loss of 50±5 g in PF and 73±5 g in L animals. Total body fat mass as measured by HMRS fell to essentially undetectable levels at days 6 and 10 in animals receiving leptin, whereas it was easily detected in the other two groups. As body mass continued to fall from day 6 to day 10 in the leptin group without any additional fall in body fat, estimated fat-free mass decreased significantly by 21 g in leptin vs. food-restricted animals. The urinary nitrogen excretion provided additional evidence for diminished fat-free mass in leptin-treated animals. It was not significantly different in the groups from days 1-5, but increased with leptin infusion from days 7-9 (277±11 vs. 215±11
72h -1 in L and PF rats, respectively). Kcal in excess of the value observed in the control group during the initial 5 days of treatment.
Since the decline in caloric intake matched the net energy deficit, energy expenditure seemed to be similar in the leptin and vehicle groups. The PF rats only experienced a net energy deficit of 80 Kcal during a time when caloric intake was reduced by 149 Kcal versus the vehicle group.
Such a difference was consistent with the oft-described limitation of energy expenditure during food restriction. Over the ten days of treatment, the net negative energy balance as determined from changes in body composition was 253 and 166 Kcal in the L and PF, respectively.
Leptin Enhances Substrate Oxidation and Depletes Intramyocellular Lipids.
These experiments directly measured key components of glucose and lipid metabolism in a single set of animals as adipose tissue fat stores were depleted over the initial 5 days of leptin treatment.
Again, three groups of animals were studied. Rats receiving ICV leptin at 50 ng . h -1 (L) were compared to littermates receiving the dilution vehicle that were either eating ad libitum (V) or were pair-fed (PF) to the leptin-treated group. Figure 2 shows the unique effect of chronic ICV leptin administration on the respiratory quotient (RQ) and resting metabolic rate (RMR) in normal rats. RQ in leptin-treated, vehicle and pair-fed rats was initially quite similar. The RQ in the V rats steadily climbed to expected levels as the animals recovered from surgical placement of ICV and arterial catheters, but remained equally suppressed in the PF and L groups. As predicted by the aforementioned body composition and caloric balance calculations, 0 2 consumption fell in the PF rats to levels below values observed in the leptin-or vehicle-treated rats having ad libitum access to food.
Daily measurements of plasma glucose, insulin, FFA and TG concentrations (Figure 3) highlighted the depletion of readily available energy substrates during continuous leptin infusion.
After maintaining normal plasma glucose concentrations for 4 d, the L group became hypoglycemic even though insulin concentrations fell to nearly undetectable levels. In addition, plasma TG and FFA levels were significantly reduced. Profound changes in tissue energy stores were also evident ( Figure 4 ). Liver glycogen content was substantially diminished, falling from 
ICV Leptin Administration in Chemically Sympathectomized
Rats. We also examined the extent to which leptin alters food intake and body weight following the interruption of sympathetic efferent activity in rats treated with guanethidine as neonates. As previous investigators have noted, the weights of the pups receiving guanethidine were reduced by 10-15% during the injection period but the rate of growth returned to normal after the injections concluded. Also, other distinct physical features were observed, including a reversible ptosis that peaked at 4-6 weeks of age and some modest diarrhea in the treated animals (27, 29, 35, 45) .
We validated the completeness of sympathectomy in guanethidine-treated animals by measuring and 47±6 in the CON and SYM groups, respectively, while the average daily food intake was 26.0±1.2 vs. 26.8±0.7 g. The interruption of sympathetic efferent activity had no discernible impact on weight loss during ICV leptin infusion but there was an unexpected difference in food intake. Figures 5 and 6 show that the SYM animals lost 25±4 g over ten days vs. 29±3 g in the CON group but they also ate significantly less food (149±5 vs. 171±5 g). Metabolic efficiency calculated as the total change in weight divided by the decrease of food intake from baseline was significantly different between the two groups (-0.21±0.03 and -0.32±0.04 in SYM and CON groups, respectively). These results indicated that weight loss during prolonged ICV infusion approximated estimated fat mass. More importantly, they pointed to an important role of sympathetic nervous system in stimulating energy expenditure by increasing either the resting metabolic rate or physical activity. We evaluated physical activity during the dark cycle using an open-field apparatus to record total active time and distance traveled ( Figure 7) . No significant differences were observed between control or sympathectomy groups receiving ICV leptin.
An additional control study verified the physiological significance of the diminished food intake in the chemically sympathectomized rats receiving ICV leptin. Littermates (n=8) that had E-00128.2002.R2
13 not been treated with guanethidine were given ICV leptin for fourteen days. We restricted food intake by pair-feeding each rat to an individual animal in the sympathectomy + leptin group for ten days before allowing the animals to eat ad libitum for four additional days. Figure 8 shows that the control + leptin + pair-fed rats lost considerably more weight, 60±9 g, than their paired counterparts in the sympathectomy + leptin group. When they were allowed free access to food on postoperative day 11, food intake increased and their weight jumped from 208±8 to 229±3 g.
DISCUSSION
The current experiments were designed to characterize the time course for the metabolic actions of intracerebroventricular leptin in normal rats and to assess the importance of the sympathetic nervous system in regulating body weight during prolonged leptin infusion. The key finding of the initial characterization study was that leptin-treated animals failed to downregulate resting energy utilization during the early hours of the light cycle to compensate for diminished food intake. The end result was excessive depletion of tissue lipid stores and hepatic glycogen in leptin-treated animals. The experiments in rats following chemical ablation of peripheral sympathetic nerves revealed that an intact sympathetic nervous system is critical for regulating body weight and peripheral metabolism during prolonged ICV leptin infusion.
When sympathectomized rats were treated with ICV leptin for ten days, their weight loss was similar to that of non-sympathectomized, leptin-treated littermates, even though they ate significantly less food. Restricting rats with intact sympathetic responses to the same food intake as the sympathectomized animals resulted in additional weight loss.
The current report focuses on a scenario in which leptin activates neurons in hypothalamic nuclei and is believed to stimulate peripheral substrate utilization via an increase in The current results and other recent studies favor the view that leptin stimulation of sympathetic activity is a key element promoting substrate utilization in tissues. Leptin has been implicated in the stimulation of the α2 catalytic subunit of the 5'-AMP-activated protein kinase (α2 AMPK) in skeletal muscle (38) . Intravenous leptin injection (1 mg/kg body weight) E-00128.2002.R2 18 stimulated α2 AMPK activity in mouse soleus muscle and increased phosphorylation of acetylCoA carboxylase, suppressing its ability to form malonyl-CoA, the endogenous inhibitor of carnitine palmitoyltransferase-I. Prolonged activation of α2 AMPK six hours after intravenous leptin administration was ablated in soleus muscle that was denervated by cutting the soleus, femoral and obturator nerves (38) . Other acute denervation experiments delineated specific effects of nerve activity on leptin action in peripheral tissues. ICV leptin administration stimulated glucose uptake in the extensor digitorum longus and soleus muscles, but this response was decreased after the femoral nerve was surgically interrupted (31) . Similarly, local denervation of interscapular brown adipose tissue impaired the ability of intrahypothalamic injections of leptin to potentiate insulin stimulated glucose uptake in that tissue (20) .
The current study is unique because peripheral sympathetic nerve terminals were specifically destroyed without the negative impact on motor function that would be expected from surgical nerve disruption. These techniques permitted close characterization of the importance of the sympathetic nervous system in regulating weight loss during prolonged leptin infusion. Specific destruction of peripheral sympathetic nerves impaired leptin acceleration of energy expenditure and limited weight loss when food intake was matched between control and sympathectomized rats. When animals had free access to food, compensatory mechanisms modulated food intake during prolonged ICV leptin infusion and minimized weight loss.
Therefore, it is evident that the sympathetic nervous system played a critical role in increasing energy expenditure and promoting weight loss in response to leptin, but even this effect was difficult to unmask unless additional factors curbed changes in food intake. In the same way, weight loss interventions that only target energy expenditure will yield disappointing results unless compensatory mechanisms that regulate energy intake are subverted as well. 
